AstraZeneca’s Symbicort for asthma available for 6-12 y.o. children in USA, FDA issues exclusivity rights
AstraZeneca’s Symbicort Inhalation Aerosol is going to be available for 6-12 years old children with asthma in the US
Pharmaceuticals, Biotechnology and Life Sciences
AstraZeneca’s Symbicort Inhalation Aerosol is going to be available for 6-12 years old children with asthma in the US
TxCell has moved into action to raise some money, as it wants to raise gross proceeds of about €11 million by issuing new shares with warrants attached.
Flu, or influenza, is a very contagious, acute, viral respiratory infection. Influenza viruses vary in a high degree. The extent…
Seasonal Affective Disorder (SAD) is a type of depression that comes and goes with the seasons, typically starting in the late fall and early winter and going away during the spring and summer. Depressive episodes linked to the summer can occur, but are much less common than winter episodes of SAD.
Pharnext, a French biopharmaceutical company focused on drugs against neurodegenerative diseases, has been named Best Life-Sciences IPO France 2016 Award.
Cervical cancer is highly preventable, yet approximately 530,000 women develop the disease each year worldwide and some 270,000 die from it unnecessarily.
A man from Bosnia has reportedly cured multiple sclerosis with cannabis oil. He was talking to CNN affiliate in Bosnia where he spoke about the hardest moments in his life, hearing about suffering from incurable disease.
The U.S. Food and Drug Administration (FDA) has noticed that lately for certain reason, there are fewer number of people willing to participate in clinical trials for different medications. Therefore, it has decided to encourage patients to take a part in helping researching companies to develop new drugs.
Author: Anna Michael, The Study Abroad Portal The Study Abroad Portal helps students worldwide to make the right decision with…
The U.S. Food and Drug Administration (FDA) has said that it plans to take a better look on how drug-makers describe their products and to make them focus on better explaining what the drug exactly do, and how consumers and healthcare professionals (HCPs) can detect false promotions.